Sort
59,101 grants matching “hypertension”
Vascular Consequences of Insulin Resistance and Obesity
$2,162,301Joseph A. Vita · Boston University Medical Campus · P50 · FY2007 · HL
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
$2,162,028Olga V Fedorova · National Institute On Aging · ZIA · FY2021 · AG
Solute And Water Transport In Renal Epithelia
$2,161,645Mark A Knepper · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
IGF::OT::IGF - Hispanic Community Health Study - Study of Latinos (HCHS-SOL) - Field Center
$2,160,654Martha Daviglus · University Of Illinois At Chicago · N01 · FY2014 · HL
Genetic & Physiological Basis of Salt-sensitive Hypertension
$2,160,350Allen W Cowley · Medical College Of Wisconsin · P01 · FY2013 · HL
iPSC Derived EC as Surrogates Using Pulmonary Hypertension as a Prototype Disease
$2,160,049Marlene Rabinovitch · Stanford University · U01 · FY2015 · HL
HORMONAL REGULATION OF BLOOD PRESSURE
$2,159,413New York Medical College · P01 · FY2003 · HL
Toxic Substances in the Environment
$2,159,198Martyn T Smith · University Of California Berkeley · P42 · FY2019 · ES
Cell-free DNA to detect transplant rejection
$2,159,104Sean Agbor-Enoh · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Collaboration to Improve Blood Pressure in the US Black Belt- Addressing the Triple Threat
$2,157,452Andrea L Cherrington · University Of Alabama At Birmingham · UH3 · FY2017 · HL
Toxic Substances in the Environment
$2,157,303Martyn T Smith · University Of California Berkeley · P42 · FY2017 · ES
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,156,509Redford B Williams · Duke University · P01 · FY2016 · HL
Risk Factors for Breast Cancer in Younger Nurses
$2,155,604Walter C. Willett · Harvard School Of Public Health · R01 · FY2010 · CA
Social and Environmental Determinants of Health Equity
$2,154,677Chandra Jackson · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Mild Cognitive Impairment: a Prospective Community Study
$2,154,423Mary Ganguli · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG
Cancer Risk in Human Populations
$2,153,446Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 3)
$2,153,335William S Kremen · University Of California, San Diego · R01 · FY2017 · AG
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$2,151,228Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Stem cell biology in cardiovascular regeneration
$2,151,181Manfred Boehm · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Novel catheter treatment of structural heart and valve disease
$2,150,654Robert J Lederman · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,150,430Colin Masters · University Of Melbourne · R01 · FY2019 · AG
Dopamine and Angiotensin Receptor Interactions in Genetic Hypertension
$2,150,160Robin A Felder · University Of Virginia · P01 · FY2010 · HL
Elafin Therapy for Lung Diseases
$2,149,054Marlene Rabinovitch · Stanford University · P01 · FY2012 · HL
GENETIC AND RECEPTOR MECHANISMS IN HYPERTENSION
$2,148,172University Of California San Diego · P01 · FY2004 · HL
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
$2,148,046Olga V Fedorova · National Institute On Aging · ZIA · FY2018 · AG